OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference
OPKO Health, Inc. (NASDAQ: OPK) will participate in the virtual Ladenburg Thalmann Healthcare Conference on July 13-14, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OPKO Health, Inc. (NASDAQ: OPK) will participate in the virtual Ladenburg Thalmann Healthcare Conference on July 13-14, 2021. Management will engage in a fireside chat on July 13 at 8:30 a.m. Eastern Time and will conduct one-on-one virtual meetings with investors throughout the day. The fireside chat will be archived in OPKO Health's Investors section on their website for future viewing. OPKO is focused on establishing a strong market position in biopharmaceuticals and diagnostics, leveraging its innovative technologies.
Details
News Market Reaction – OPK
The recorded move for OPK in the trading session of this news was +3.08%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, July 08, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the Ladenburg Thalmann Healthcare Conference being held virtually July 13-14, 2021. Management will be interviewed in a fireside chat format on Tuesday, July 13th at 8:30 a.m. Eastern time and will also be holding one-on-one virtual meetings with investors throughout the day.
The fireside chat will be archived in the Investors section of OPKO Health’s website and will be available here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.